PowerPoint Presentation

IlcnaHKa H 1 IN 1 4U-öU cax A3111iH TOM 1957 YYJIHIIH 2N2 331 1-2 caq EOHI'KOHrH1iH TO 1968 4 2n2 ak0YJ11 Bilpyc 3J1 1 cu Faxai1H TO 2009 HINI JI p 00 MHHra SARS KOPOHaBH 2002 77 c COVID-19 OHaBII 2019 2UU9-HlNl-17.4% 1 632 258 xawwap- 284 500 214 2019-nCov-3.5U/0 124 cax xa-uuap- 2.73 c 2002-SARS-9.30/0 8 096 OBAJ1en-774 29 Vilc 2012-MERS-34.40/0 2 519 xa.uwap- 866 27 2003-H5N1-52.80/0 861 OBIIneJ1-455 3HÅ3JIT 18 ync 2013-H7N9-39.3% 1 568 xaJIÅBap- 616 3HÅ3JIT.

95 60 76 76 51 76 Miniopterus bat coronavirus 1 Miniopterus bat coronavirus HKU8 Miniopterus bat coronavirus HKU7 Myotis bat coronavirus HKU6 Scotophilus bat coronavirus 512 Porcine epidemic diarrhea virus Human coronavirus 229E Human coronavirus NL63 Rhinolophus bat coronavirus HKlJ2 Feline infectious peritonitis virus Transmissible gastroenteritis virus uman coronavirus HK Murine hepatitis virus Human coronavirus OC43 Bovine coronavirus Rousettus bat coronavirus HKU9 SARS-related bat coronavi Human SARS ronavirus Tylonycteris bat coronavirus HKU4 Pipistrellus bat coronav Human MER oronavirus Avian infectious bronchitis virus Beluga whale coronavirus SWI Munia coronavirus HKUI 3 Asian leopard cat coronavirus Bulbul mronavirus HKUI 1 c 70 0.05 87 100 78 Alphacoronavirus mus Gammacoronavirus Delta coronavirus 1 .Richard A. Kaslow, Lawrence R. James W. Le Duc Viral Infections of Humans Springer US, 2014; SARS SARS-Cov Receptor ACE2 MERS MERS-CoV Receptor DPP4 2019-nCoV SARS-CoV-2 Receptor ACE2.

ARS.CoV.2 Viral RNA and RNA Replication Struterd SARS.CoV.2 Rek•se Of •f Mature in • Vesick Golgi Apparatus cea (APO Rek•g oo 00 Transbtioa or and Accessory Proteins and E.doplasmic iculum ERY AHTWCH npe3eHTHHT Synthesized Viral Proteins from ER to Gagi Anantus (InvivoGen, 2020).

I..WCHH Aapaax xymyyc • Xenanre6H 6ararai M.MOKapß.n».HH unppn-n UUJA.m 6aitcaH, 3ypxHHä øme,hMäH • YymrHHH 3M60JIH ryBni cyaaCHh1.

HEALTHY LUNGS HEALTHY ALVEOLI normal LUNGS OF A SMOKER ALVEOLI WITH EMPHYSEMA damaged alveoli KAPAMO n•Mf1 TPOM603 HeKP03 TKaHei.